Erythrophages do not develop when lumbar CSF and blood samples are mixed in vitro

R. Dersch*, D. Benkler, T. Robinson, A. Baumgartner, S. Rauer, O. Stich

*Korrespondierende/r Autor/-in für diese Arbeit
1 Zitat (Scopus)

Abstract

Background: Cerebrospinal fluid (CSF) analysis is a crucial method in the diagnostic process for suspected subarachnoid hemorrhage (SAH), especially when cerebral imaging is negative or inconclusive. CSF cytology (detection of erythrophages or siderophages) is used to determine whether a bloodstained CSF resembles a genuine SAH. Whether erythrophages may develop in vitro after a traumatic puncture in case of delayed CSF analysis is unclear. An in vitro development of erythrophages after traumatic puncture would diminish the diagnostic properties of CSF analysis. We assessed whether erythrophagocytosis is detectable in CSF after an imitated traumatic lumbar puncture. Methods: We mimicked a traumatic lumbar puncture by mixing surplus CSF with whole blood from the same patient. From this mixture, cytological specimens were obtained immediately and repeatedly at time intervals of 1 h, until 7 h after mixing, or until the mixture was exhausted. Each cytological specimen was microscopically examined independently by four experienced CSF cytologists for the presence of erythrophages. Results: We studied 401 CSF cytological specimens of 96 punctures in 90 patients. We could not identify any erythrophages in all cytological specimens. Fleiss' Kappa for interrater-reliability was 1.0. Conclusions: We did not find evidence for an in vitro erythrophagocytosis after a mimicked traumatic lumbar puncture. Therefore, the occurrence of erythrophages in CSF cytology can be regarded as a reliable sign of an autochthonous bleeding in the subarachnoid space. Our results support the crucial role of CSF analysis in clinical practice in case of a suspected SAH but negative cerebral imaging.

OriginalspracheEnglisch
Aufsatznummer31
ZeitschriftFluids and Barriers of the CNS
Jahrgang15
Ausgabenummer1
DOIs
PublikationsstatusVeröffentlicht - 05.11.2018

Fördermittel

RD, and DB report no competing interest. TH received travel grants from Bayer Vital GmbH and Novartis. AB received lecture fees, travel grants, and research support from Bayer Vital GmbH, Biogen Idec GmbH, Genzyme and Novartis. SR reports receiving consulting and lecture fees, grant, and research support from Bayer Vital GmbH, Biogen Idec, Merck Serono, Novartis, Sanofi-Aventis, Baxter, RG, and Teva. Furthermore, SR indicates that he is a founding executive board member of ravo Diagnostika GmbH. OS reports receiving consulting and lecture fees, grant, and research support from Baxter, Bayer Vital GmbH, Biogen Idec, Genzyme, Merck Serono, Novartis, RG, Sanofi-Aventis and Teva. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.

Strategische Forschungsbereiche und Zentren

  • Querschnittsbereich: Gesundheitswissenschaften: Logopädie, Ergotherapie, Physiotherapie und Hebammenwissenschaft

DFG-Fachsystematik

  • 2.22-14 Hämatologie, Onkologie
  • 2.23-07 Klinische Neurologie, Neurochirurgie und Neuroradiologie

Fingerprint

Untersuchen Sie die Forschungsthemen von „Erythrophages do not develop when lumbar CSF and blood samples are mixed in vitro“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren